EUVIMEDEUVIMED entdecken
Open Access

Plasma metabolomics in infancy reveals early signatures of a stringently‐defined otitis‐prone phenotype

Nicole Prince iD, Jing Chen iD, Ravinder Kaur iD, Caitlin Syphurs iD, Annmarie Hoch iD, Asimenia Angelidou iD, Kerry McEnaney iD, Bo Chawes iD, Ole Bæk iD, Tingting Wang iD, Nicklas Brustad iD, Ofer Levy iD und 4 weitere

Pediatric Allergy and Immunology · 2026-08 · 37 (8)

DOI: 10.1111/pai.70428 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 17.08.2026. Verfasst von Nicole Prince und 15 weiteren Autor:innen. Beteiligte Einrichtung: Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Otitis Media. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Institute of Allergy and Infectious Diseases, NIAID NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Otitis media is highly prevalent during early life, yet the molecular factors that predispose children to recurrent episodes are poorly defined. Metabolomics captures dynamic biochemical changes and may help identify pathways influencing otitis susceptibility. We examined whether longitudinal infant plasma metabolomic profiles were associated with development of stringently‐defined otitis proneness in the Rochester Combined Cohort (RCC; Rochester, NY).

Methods

Global plasma metabolomic profiling was performed in RCC samples collected between ~6 and 18 months of age using liquid chromatography–tandem mass spectrometry (LC–MS/MS). Children were classified as stringently‐defined otitis prone (sOP) if they experienced ≥3 acute otitis media (AOM) episodes within a 6‐month period or ≥4 AOM episodes within a 12‐month period during the first 3 years of life; all AOM episodes were tympanocentesis‐confirmed. Generalized additive mixed models (GAMMs) assessed age‐dependent differences in plasma metabolite levels between sOP and non‐otitis‐prone (nOP) children, adjusting for potential confounders.

Results

Several metabolites demonstrated age‐related declines in lipid and amino acid pathways, with consistently lower metabolite trajectories in the sOP group. Compared with nOP children, sOP children exhibited significantly lower levels of 16 metabolites related to inflammatory lipid signaling, redox metabolism, and fatty acid metabolism ( p < 4.4 × 10 −4 ) and higher levels of glycerophosphoinositol ( p = 2.9 × 10 −4 ). These findings were directionally consistent in a sensitivity analysis additionally adjusted for recent antibiotic use.

Conclusion

Children who subsequently met sOP criteria by age 3 years exhibited distinct plasma metabolomic signatures during infancy, suggesting altered immune–metabolic programming preceding recurrent otitis media. Longitudinal metabolomics provides a promising framework to identify biochemical mechanisms underlying otitis proneness.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Otitis MediaHumansMetabolomicsInfantFemaleMalePhenotypeTandem Mass SpectrometryBiomarkersMetabolomeChromatography, LiquidLongitudinal StudiesCohort Studies

Stichwörter der Autor:innen

immune developmentlongitudinal omicsmetabolomicsotitis proneness

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Research Computing, Boston Children's Hospital, Boston, Massachusetts, USA.
  • Center for Infectious Diseases and Immunology, Rochester General Hospital Research Institute, Rochester, New York, USA.
  • Department of Neonatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.

ORCID-Profile: Nicole Prince, Jing Chen, Ravinder Kaur, Caitlin Syphurs, Annmarie Hoch, Asimenia Angelidou, Kerry McEnaney, Bo Chawes, Ole Bæk, Tingting Wang, Nicklas Brustad, Ofer Levy, Joann Diray-Arce, Michael Pichichero, Jessica A Lasky-Su

Förderung

  • National Institute of Allergy and Infectious Diseases
  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NIDCD NIH HHS
  • National Institute on Deafness and Other Communication Disorders
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Prince, N., Chen, J., Kaur, R., Syphurs, C., Hoch, A., Angelidou, A., McEnaney, K., Chawes, B., Bæk, O., Wang, T., Brustad, N., Levy, O., Diray-Arce, J., Pichichero, M., Lasky-Su, J. A., & IDEaL Consortium (2026). Plasma metabolomics in infancy reveals early signatures of a stringently‐defined otitis‐prone phenotype. Pediatric Allergy and Immunology, 37(8). https://doi.org/10.1111/pai.70428

Vancouver

Prince N, Chen J, Kaur R, Syphurs C, Hoch A, Angelidou A, et al. Plasma metabolomics in infancy reveals early signatures of a stringently‐defined otitis‐prone phenotype. Pediatric Allergy and Immunology. 2026;37(8). doi:10.1111/pai.70428

BibTeX
@article{Prince2026,
  author = {Prince, Nicole and Chen, Jing and Kaur, Ravinder and Syphurs, Caitlin and Hoch, Annmarie and Angelidou, Asimenia and McEnaney, Kerry and Chawes, Bo and Bæk, Ole and Wang, Tingting and Brustad, Nicklas and Levy, Ofer and Diray-Arce, Joann and Pichichero, Michael and Lasky-Su, Jessica A and IDEaL Consortium, IDEaL Consortium},
  title = {Plasma metabolomics in infancy reveals early signatures of a stringently‐defined otitis‐prone phenotype},
  journal = {Pediatric Allergy and Immunology},
  year = {2026},
  volume = {37},
  number = {8},
  doi = {10.1111/pai.70428}
}
Kostenlos starten →